Myriad Genetics, Inc. (MYGN) by event type
MYGN moves most on analyst upgrades — a median of +0.92% at 30 minutes across 17 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the MYGN overview →
How MYGN reacts across 5 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 155 of 2,717 | 17 | +0.92% | 71% | -0.99% |
| Analyst downgrades 710 of 2,603 | 29 | +0.23% | 59% | +0.88% |
| Coverage initiations 1,651 of 2,283 | 31 | -0.20% | 42% | +1.87% |
| Rating reiterations 3,083 of 3,522 | 46 | -0.27% | 46% | -0.69% |
| Price-target cuts 1,476 of 1,527 | 18 | -0.65% | 28% | -0.25% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.
That’s how MYGN usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target cuts → · MYGN overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| VICAL (VICL) | 574 | -0.00% | 38% |
| Becton, Dickinson and Company (BDX) | 573 | -0.01% | 50% |
| Tilray Brands, Inc. (TLRY) | 558 | -0.32% | 41% |
| PERNIX THERAPEUTICS HOLDINGS (PTX) | 557 | -0.19% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.